Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Iclusig Recall Issued Due to Risk of Blood Clots, Blood Vessel Narrowing November 4, 2013 Irvin Jackson Add Your Comments Due to the risk of severe and potentially life-threatening blood clots from side effects of Iclusig, Ariad Pharmaceuticals has agreed to suspend sales of the recently introduced leukemia drug. On October 31, the FDA updated a drug safety communication to announce that the agency asked Ariad to remove Iclusig from the market amid reports of blood clots and severe narrowing of blood vessels. The agency first issued a warning about the potential Iclusig risks on October 11, announcing that the FDA was investigating an increasing frequency of adverse event reports since the medication was approved in December 2012. As a result of the blood clot problems, Ariad also halted clinical trials due to the potential risks test subjects faced. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Iclusig (ponatinib) was approved less than a year ago for treatment of chronic phase, accelerated phase, or blast phase chronic myeloid leukemia or Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia. It is reserved for patients who no longer benefit from or tolerate other treatments. When the drug was first put on the market, it was known that Iclusig increased the risk of blood clots, but it appears the level of that risk is much higher than the FDA was originally told. The original clinical trial data Ariad gave to the FDA showed the development of blood clots in 8% of Iclusing users. However, once the drug was on sale to the public, clinical trial data indicated that 24% of Iclusig users studied over a median of 1.3 years suffered serious adverse vascular events. That number jumped to 48%, nearly half, when the median was 2.7 years of use. According to the FDA, data from the clinical trials showed patients suffered heart attacks, death, worsening coronary artery disease, stroke, restricted arteries of the brain and blood vessels in the extremities and the “need for urgent surgical procedures to restore blood flow.” Other problems the FDA reports that patients have experienced include congestive heart failure and tissue death requiring amputation. There have also been reports of vision loss and clots of blood vessels in the eye. The suspension may not result in a permanent Iclusig recall, as FDA officials are continuing to study the medication to better understand the risks of the drug and to determine if there are patient populations for whom the benefits outweigh the risks. The agency advises patients to discuss whether they should continue to use the drug with their doctors. The FDA warns that patients taking Iclusig should seek immediate medical attention if they experience symptoms like those of a heart attack or stroke, including: Chest pain or pressure Pain in the arms, back neck or jaw Shortness of breath Numbness or weakness on one side of the body Trouble talking Severe headache Dizziness Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Blood Clot, Cancer, Heart Attack, Iclusig, Leukemia, Stroke Image Credit: | More Lawsuit Stories Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures October 27, 2025 Similac Lawsuit Claims Infant Formula Side Effects Led to Preemie’s Death October 27, 2025 Information About 2,500 Camp Lejeune Injury Claims May Influence Settlement Process October 27, 2025 0 Comments InstagramThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (Posted: yesterday) Breast mesh products marketed as “internal bras” for lift and augmentation surgeries are now under investigation amid reports of painful complications, and questions over manufacturers’ prior knowledge of mesh-related risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Problems Prompted FDA Warnings Over Off-Label Use (10/15/2025)Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023) Four BioZorb Breast Marker Lawsuits Set for Trial Between Jan. and April 2026 (Posted: 4 days ago) A federal judge has set key scheduling deadlines for the four first bellwether trials over claims that BioZorb breast markers are defectively designed. MORE ABOUT: BIOZORB LAWSUITLawyers in BioZorb Implant Lawsuits Request Updated Deadlines in Pretrial Schedule (10/15/2025)Tamoxifen Side Effects Linked to Uterine Tumors in Breast Cancer Patients: Study (09/16/2025)Five Women File Joint Lawsuit Over BioZorb Breast Implant Side Effects (09/09/2025) Lawsuits Over Depo-Provera and Meningioma To Be Coordinated Between Federal and State Courts (Posted: 5 days ago) Parties in federal Depo-Provera meningioma lawsuits seek closer coordination with Delaware and New York state courts, proposing a synchronization of general causation schedules. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Side Effects Hidden for Decades, Lawsuit Alleges (10/20/2025)Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (10/06/2025)Depo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)
Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures October 27, 2025
Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (Posted: yesterday) Breast mesh products marketed as “internal bras” for lift and augmentation surgeries are now under investigation amid reports of painful complications, and questions over manufacturers’ prior knowledge of mesh-related risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Problems Prompted FDA Warnings Over Off-Label Use (10/15/2025)Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Four BioZorb Breast Marker Lawsuits Set for Trial Between Jan. and April 2026 (Posted: 4 days ago) A federal judge has set key scheduling deadlines for the four first bellwether trials over claims that BioZorb breast markers are defectively designed. MORE ABOUT: BIOZORB LAWSUITLawyers in BioZorb Implant Lawsuits Request Updated Deadlines in Pretrial Schedule (10/15/2025)Tamoxifen Side Effects Linked to Uterine Tumors in Breast Cancer Patients: Study (09/16/2025)Five Women File Joint Lawsuit Over BioZorb Breast Implant Side Effects (09/09/2025)
Lawsuits Over Depo-Provera and Meningioma To Be Coordinated Between Federal and State Courts (Posted: 5 days ago) Parties in federal Depo-Provera meningioma lawsuits seek closer coordination with Delaware and New York state courts, proposing a synchronization of general causation schedules. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Side Effects Hidden for Decades, Lawsuit Alleges (10/20/2025)Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (10/06/2025)Depo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)